- Home
- VIRT vs KLTOW Comparison
VIRT vs KLTOW Comparison
Compare VIRT & KLTOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VIRT | KLTOW |
|---|---|---|
| Founded | 2008 | N/A |
| Country | United States | United States |
| Employees | N/A | 3 |
| Industry | Investment Bankers/Brokers/Service | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | N/A |
| IPO Year | 2015 | 2022 |
Fundamental Metrics
Financial Performance| Metric | VIRT | KLTOW |
|---|---|---|
| Price | $33.50 | $0.10 |
| Analyst Decision | Hold | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $41.43 | N/A |
| AVG Volume (30 Days) | ★ 831.3K | N/A |
| Earning Date | 01-28-2026 | N/A |
| Dividend Yield | ★ 2.85% | N/A |
| EPS Growth | ★ 132.69 | N/A |
| EPS | ★ 4.62 | N/A |
| Revenue | ★ $2,694,104,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $7.30 | ★ N/A |
| Revenue Growth | ★ 41.05 | N/A |
| 52 Week Low | $31.89 | N/A |
| 52 Week High | $45.77 | N/A |
Technical Indicators
Market Signals| Indicator | VIRT | KLTOW |
|---|---|---|
| Relative Strength Index (RSI) | 39.65 | 40.12 |
| Support Level | $32.87 | $0.13 |
| Resistance Level | $34.52 | $0.15 |
| Average True Range (ATR) | 0.89 | 0.02 |
| MACD | -0.19 | -0.00 |
| Stochastic Oscillator | 18.20 | 43.91 |
Price Performance
Historical ComparisonAbout VIRT Virtu Financial Inc.
Virtu Financial Inc is a financial firm that leverages technology to deliver liquidity to the world-wide markets and transparent trading solutions to its clients. The company's operating segment includes Market Making; and Execution Services. The non-operating segment of the company includes the Corporate segment. The company generates maximum revenue from the market-making segment. The Market Making segment principally consists of market-making in the cash, futures, and options markets across equities, options, fixed income, currencies, and commodities. Geographically, it derives a majority of its revenue from the United States and also has a presence in Ireland and Other Countries.
About KLTOW Klotho Neurosciences Inc. Warrant
Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.